Article
Stem cells in cancer initiation and progression
24 Dec 2019
Abstract excerpt
While standard therapies can lead to an initial remission of aggressive cancers, they are often only a transient solution. The resistance and relapse that follows is driven by tumor heterogeneity and therapy-resistant populations that can reinitiate growth and promote disease progression. There is thus a significant need to understand the cell types and signaling pathways that not only contribute to cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.